Alerts will be sent to your verified email
Verify Email
VEL
|
Vaxfab Enterprise
|
Sanblue Corporation
|
Rubra Medicaments
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
-8.32 % | -0.33 % | -2.03 % |
|
5yr average Equity Multiplier
|
1.33 | 1.11 | 1.44 |
|
5yr Average Asset Turnover Ratio
|
0.41 | 0.03 | 1.44 |
|
5yr Avg Net Profit Margin
|
-11.8 % | -33.24 % | -0.31 % |
|
Price to Book
|
1.7 | 0.53 | 50.18 |
|
P/E
|
71.7 | 91.44 | 318.39 |
|
5yr Avg Cash Conversion Cycle
|
-19.53 Days | 15.07 Days | 183.71 Days |
|
Inventory Days
|
121.42 Days | 55.57 Days | 0.0 |
|
Days Receivable
|
158.29 Days | 22.24 Days | 183.71 Days |
|
Days Payable
|
130.94 Days | 397.76 Days | 33.56 Days |
|
5yr Average Interest Coverage Ratio
|
45.42 | 657.93 | -248.31 |
|
5yr Avg ROCE
|
1.4 % | -0.32 % | -2.28 % |
|
5yr Avg Operating Profit Margin
|
-9.6 % | -57.57 % | -0.3 % |
|
5 yr average Debt to Equity
|
0.01 | 0.01 | 0.06 |
|
5yr CAGR Net Profit
|
n/a | n/a | 0.0 |
|
5yr Average Return on Assets
|
-6.15 % | -0.35 % | -1.63 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
0.0 | 66.81 % | 0.0 |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
-0.78 % | 0.0 | 0.0 |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Vaxfab Enterprise
|
Sanblue Corporation
|
Rubra Medicaments
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|